Position
Chief Medical Officer
Company
Sail Biomedicines
Description
Sail Biomedicines has appointed Dr. Gene Marcantonio as Chief Medical Officer. He brings extensive experience in translation medicine and immunology, crucial for advancing the company’s lead In Vivo eRNA-TNP CAR-T program for autoimmune diseases.
Quick answer
Sail Biomedicines Appoints Dr. Gene Marcantonio as Chief Medical Officer (May 5, 2026). Sail Biomedicines is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Medical Officer at Sail Biomedicines?
- Sail Biomedicines named Gene Marcantonio Chief Medical Officer, announced May 5, 2026.
- What did Sail Biomedicines announce on May 5, 2026?
- Sail Biomedicines has appointed Dr. Gene Marcantonio as Chief Medical Officer. He brings extensive experience in translation medicine and immunology, crucial for advancing the company’s lead In Vivo eRNA-TNP CAR-T program for autoimmune diseases.
- What does Sail Biomedicines do?
- Sail Biomedicines, a Flagship Pioneering company, is generating tomorrow’s medicines today through the language of life.
- Where is Sail Biomedicines based?
- Sail Biomedicines is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Edwards Lifesciences (May 5, 2026), NetraMark (May 4, 2026), Eko Health (May 7, 2026) and Infinitopes (May 12, 2026) also announced leadership changes within 45 days of Sail Biomedicines.
Source: Fundz verified event record.
Other recent leadership changes in Biotechnology and Health Care
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Edwards Lifesciences Appoints Theodora Mistras as Chief Financial Officer (May 5, 2026)
- NetraMark Appoints Dr. Panteli Theocharous as Fractional Chief Medical Officer (May 4, 2026)
- Eko Health Appoints Steven R. Steinhubl as Chief Medical Officer (May 7, 2026)
- Infinitopes Appoints Jo Brewer as Chief Scientific Officer (May 12, 2026)
- Zimmer Biomet Appoints Paul Stellato as Interim Chief Financial Officer (April 28, 2026)
- Eyoto Appoints Tony Veverka as Interim Chief Executive Officer (April 24, 2026)
Who to call at Sail Biomedicines, and when
A new leader at Sail Biomedicines brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Sail Biomedicines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sail Biomedicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sail Biomedicines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sail Biomedicines changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Sail Biomedicines changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.